The store will not work correctly when cookies are disabled.
6-chloro-4-ethoxy-3-methyl-4-phenyl-3,4-dihydroquinazoline-2(1H)-thione
ID: ALA4483481
PubChem CID: 155540485
Max Phase: Preclinical
Molecular Formula: C17H17ClN2OS
Molecular Weight: 332.86
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC1(c2ccccc2)c2cc(Cl)ccc2NC(=S)N1C
Standard InChI: InChI=1S/C17H17ClN2OS/c1-3-21-17(12-7-5-4-6-8-12)14-11-13(18)9-10-15(14)19-16(22)20(17)2/h4-11H,3H2,1-2H3,(H,19,22)
Standard InChI Key: KKRIIQWMMUVKTF-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
12.3059 -20.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7216 -21.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1330 -20.9964 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5874 -22.1339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5863 -22.9594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2995 -23.3713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2976 -21.7221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0115 -22.1302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0103 -22.9569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7217 -23.3689 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4388 -22.9589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4399 -22.1322 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1539 -21.7225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1504 -23.3724 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.9561 -20.9940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3656 -20.2798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7202 -20.2818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3052 -19.5672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4772 -19.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0660 -20.2919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4833 -21.0036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8744 -21.7225 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 2 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 2 1 0
12 13 1 0
11 14 2 0
3 15 1 0
15 16 1 0
1 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 1 1 0
4 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.86 | Molecular Weight (Monoisotopic): 332.0750 | AlogP: 4.22 | #Rotatable Bonds: 3 |
Polar Surface Area: 24.50 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.86 | CX Basic pKa: ┄ | CX LogP: 5.16 | CX LogD: 5.16 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.85 | Np Likeness Score: -0.45 |
References
1. Namasivayam V, Vanangamudi M, Kramer VG, Kurup S, Zhan P, Liu X, Kongsted J, Byrareddy SN.. (2019) The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic., 62 (10): [PMID:30516990] [10.1021/acs.jmedchem.8b00843] |